tiprankstipranks
Advertisement
Advertisement

INBX Stock Latest News

Inhibrx reports Q2 EPS ($2.34), consensus ($1.85)
The FlyInhibrx reports Q2 EPS ($2.34), consensus ($1.85)
12h ago
INBX
Buy Rating Reaffirmed on Inhibrx Ahead of Key INBRX-106 Phase 2 Readout; $230 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on Inhibrx Ahead of Key INBRX-106 Phase 2 Readout; $230 Price Target Maintained
2d ago
INBX
Inhibrx Biosciences Expands Credit Facility to $500 Million
PremiumCompany Announcements
Inhibrx Biosciences Expands Credit Facility to $500 Million
1M ago
8K
INBX
Citizens healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens healthcare analysts hold an analyst/industry conference call
1M ago
CTMX
EXEL
Inhibrx Biosciences BLA Accepted for Ozekibart Chondrosarcoma Therapy
PremiumCompany Announcements
Inhibrx Biosciences BLA Accepted for Ozekibart Chondrosarcoma Therapy
2M ago
8K
INBX
Inhibrx announces FDA acceptance of BLA for ozekibart
PremiumThe FlyInhibrx announces FDA acceptance of BLA for ozekibart
2M ago
INBX
Inhibrx Biosciences Holds 2026 Virtual Annual Shareholder Meeting
Premium
Company Announcements
Inhibrx Biosciences Holds 2026 Virtual Annual Shareholder Meeting
2M ago
8K
INBX
Inhibrx price target raised to $325 from $300 at Stifel
Premium
The Fly
Inhibrx price target raised to $325 from $300 at Stifel
3M ago
INBX
Inhibrx reports Q1 EPS ($2.15) vs. ($2.80) last year
PremiumThe Fly
Inhibrx reports Q1 EPS ($2.15) vs. ($2.80) last year
3M ago
INBX
Inhibrx Biosciences Reports Positive Interim Phase 2 Results
PremiumCompany Announcements
Inhibrx Biosciences Reports Positive Interim Phase 2 Results
3M ago
8K
INBX
Inhibrx’s INBRX-106 shows potential benefit in HNSCC
PremiumThe Fly
Inhibrx’s INBRX-106 shows potential benefit in HNSCC
3M ago
INBX
Inhibrx initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Inhibrx initiated with an Outperform at LifeSci Capital
4M ago
INBX
Inhibrx price target raised to $300 from $150 at Stifel
PremiumThe FlyInhibrx price target raised to $300 from $150 at Stifel
4M ago
INBX
Midday Fly By: Boeing, AT&T report Q1 beats
Premium
The Fly
Midday Fly By: Boeing, AT&T report Q1 beats
4M ago
T
BA
Inhibrx trading halted, volatility trading pause
Premium
The Fly
Inhibrx trading halted, volatility trading pause
4M ago
INBX
Inhibrx trading resumes
PremiumThe Fly
Inhibrx trading resumes
4M ago
INBX
Inhibrx’s cancer drug drawing interest from Merck, Ono, Reuters says
PremiumThe Fly
Inhibrx’s cancer drug drawing interest from Merck, Ono, Reuters says
4M ago
MRK
INBX
Inhibrx up 39% at $117 after report of interest from Merck in cancer assets
PremiumThe Fly
Inhibrx up 39% at $117 after report of interest from Merck in cancer assets
4M ago
INBX
Inhibrx Biosciences Highlights Promising Ozekibart Colorectal Cancer Data
PremiumCompany Announcements
Inhibrx Biosciences Highlights Promising Ozekibart Colorectal Cancer Data
4M ago
8K
INBX
Inhibrx reports interim data from its Phase 1/2 study evaluating ozekibart
PremiumThe FlyInhibrx reports interim data from its Phase 1/2 study evaluating ozekibart
4M ago
INBX
Coinbase downgraded, Deere upgraded: Wall Street’s top analyst calls
Premium
The Fly
Coinbase downgraded, Deere upgraded: Wall Street’s top analyst calls
4M ago
DE
GD
Inhibrx initiated with a Buy at Stifel
Premium
The Fly
Inhibrx initiated with a Buy at Stifel
4M ago
INBX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >